The FDA has approved Merck's KEYTRUDA for treating locally advanced head and neck squamous cell carcinoma, marking a significant advancement in cancer treatment. This new regimen, validated by the KEYNOTE-689 trial, significantly extends event-free survival, offering fresh hope for patients.

BioRestorative Therapies revealed promising preliminary results for BRTX-100, a stem cell therapy for chronic lumbar disc disease, at ISSCR 2025 in Hong Kong. Despite positive trial data and no serious side effects, regulatory hurdles and investor skepticism persist, impacting stock performance.

A new study reveals vaccinated COVID-19 patients with acute kidney injury (AKI) fare better than unvaccinated ones, showing reduced dialysis and mortality risks. The research, involving data from 3,500 hospitalized patients, emphasizes the ongoing need to explore COVID-19’s impact on kidney health, amid evolving vaccine recommendations.

Stanford researchers have developed innovative 3D bioprinting tools to create complex vascular networks, crucial for printing functional organs like the human heart. This breakthrough could revolutionize organ transplants by enhancing cell survival and nutrient delivery, potentially leading to full organ printing within five years.

A new study in Nature Neuroscience reveals specific brain cells responsive to exercise, hinting at potential Alzheimer's drug targets. Research shows exercise improves memory in mice, emphasizing the hippocampus's role in this process.

Hiroshima University researchers have identified a promising anticancer compound targeting breast cancer through the disruption of VIPR2 receptor dimerization. The study, published in the British Journal of Pharmacology, highlights TM3-4 peptides as potential inhibitors of tumor growth and metastasis, paving the way for new drug development.

A study by City of Hope reveals that analyzing extrachromosomal DNA (ecDNA) can predict how mutated genes impact cancer progression and treatment resistance. This could revolutionize personalized cancer therapy by identifying new therapeutic targets and understanding tumor evolution.

Dr. Mohan will be honored with an award at the EASD's 61st Annual Meeting in Vienna this September for his pivotal work in diabetes research and care. His efforts have notably advanced diabetes treatment, particularly in India.

Johns Hopkins researchers have identified tumor DNA in bloodstreams up to three years before cancer diagnosis, heralding a new era of early cancer detection. This study, supported by major institutions, sets crucial benchmarks for multicancer early detection tests.

Michigan State University joined 18 other research institutions in supporting Harvard College's lawsuit against the Trump administration's $2.2 billion federal research grant freeze. The universities argue that cutting federal funds threatens scientific progress and national security, emphasizing the crucial role of government partnerships.

University of Maryland's Quantum Systems Accelerator achieves breakthrough in quantum computing with parallel gate operations and mid-circuit measurement techniques. Collaborations with Duke and Sandia Labs enhance entanglement and reduce power dissipation, paving the way for scalable quantum systems.

The FDA has expanded Moderna's RSV mRNA vaccine approval to high-risk adults aged 18-59, marking its first non-COVID mRNA vaccine in the U.S. CDC recommendation is awaited to ensure health insurance coverage, amid skepticism and leadership changes at the CDC.

Discovery of Jezero Mons, a potential volcano near Mars' Jezero crater, could revolutionize our understanding of Martian geology, with Perseverance possibly holding vital samples. This dormant volcano, comparable to Earth's Mount Sidley, suggests Mars' volcanic history might be more recent and complex than previously thought.

Scientists have developed a computer simulation to predict SKA-Low telescope observations, crucial for detecting early universe signals from the Cosmic Dawn and Epoch of Reionization. This simulation aids in overcoming challenges posed by faint signals amidst significant foreground noise, enhancing our understanding of the universe's first light sources.

A study in the Journal of Proteome Research reveals severe COVID-19 and MIS-C in children cause significant metabolic disruptions, affecting heart health long-term. Researchers urge more studies into these lasting effects as children with MIS-C face serious cardiac and metabolic issues.

Researchers at the Technical University of Munich have created a PET-based technique to track modified immune cells in immunotherapy, potentially boosting treatment effectiveness and safety. This method allows real-time visualization of cell behavior within the body, though it requires further clinical trials before human application.

A Cambridge-led clinical trial achieved a groundbreaking 100% survival rate for aggressive breast cancer patients using a combination of chemotherapy and Olaparib. Researchers emphasize further studies are necessary to validate these promising results, which could transform treatment, especially for BRCA mutation-related cancers.

NASA's Chandra X-ray Observatory uncovered a massive jet from supermassive black hole J1610+1811, 11.6 billion light-years away. This discovery marks a pivotal moment in cosmic exploration amid budget concerns.

The James Webb Space Telescope has observed two gas giant planets at different developmental stages orbiting young star YSES-1, 310 light-years away. This discovery, led by Dr. Kielan K. W. Hoch, offers unprecedented insights into planetary formation, challenging existing theories and showcasing JWST's capabilities.